These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19487249

  • 1. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ, Chang TK.
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [Abstract] [Full Text] [Related]

  • 2. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK, Chen J, Yeung EY.
    Toxicol Appl Pharmacol; 2006 May 15; 213(1):18-26. PubMed ID: 16226778
    [Abstract] [Full Text] [Related]

  • 3. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If, Chen J, Chang TK.
    Can J Physiol Pharmacol; 2004 Jan 15; 82(1):57-64. PubMed ID: 15052306
    [Abstract] [Full Text] [Related]

  • 4. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype.
    Numa AM, Abbott FS, Chang TK.
    Can J Physiol Pharmacol; 2007 Sep 15; 85(9):848-55. PubMed ID: 18066130
    [Abstract] [Full Text] [Related]

  • 5. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2000 Oct 15; 28(10):1176-83. PubMed ID: 10997936
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O.
    Drug Metab Dispos; 2004 Jun 15; 32(6):626-31. PubMed ID: 15155554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A sensitive and selective multiple reaction monitoring mass spectrometry method for simultaneous quantification of flavonol glycoside, terpene lactones, and biflavonoids in Ginkgo biloba leaves.
    Wang LT, Fan XH, Jian Y, Dong MZ, Yang Q, Meng D, Fu YJ.
    J Pharm Biomed Anal; 2019 Jun 05; 170():335-340. PubMed ID: 30986686
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
    Mohamed MF, Frye RF.
    Drug Metab Dispos; 2010 Feb 05; 38(2):270-5. PubMed ID: 19889883
    [Abstract] [Full Text] [Related]

  • 14. Direct analysis of 18 flavonol glycosides, aglycones and terpene trilactones in Ginkgo biloba tablets by matrix solid phase dispersion coupled with ultra-high performance liquid chromatography tandem triple quadrupole mass spectrometry.
    Liu XG, Yang H, Cheng XL, Liu L, Qin Y, Wang Q, Qi LW, Li P.
    J Pharm Biomed Anal; 2014 Aug 05; 97():123-8. PubMed ID: 24876067
    [Abstract] [Full Text] [Related]

  • 15. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
    Richter T, Mürdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M, Eichelbaum M, Zanger UM.
    J Pharmacol Exp Ther; 2004 Jan 05; 308(1):189-97. PubMed ID: 14563790
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
    Sridar C, Kenaan C, Hollenberg PF.
    Drug Metab Dispos; 2012 Dec 05; 40(12):2256-66. PubMed ID: 22936314
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
    Palovaara S, Pelkonen O, Uusitalo J, Lundgren S, Laine K.
    Clin Pharmacol Ther; 2003 Oct 05; 74(4):326-33. PubMed ID: 14534519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.